Latest Breaking News On - International journal of virtual reality - Page 1 : comparemela.com

/PRNewswire/ Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported results in a Phase II clinical study of VQW-765, a novel small molecule alpha.

United statesKevin moranVanda pharmaceuticals incCommunity samplePrnewswire vanda pharmaceuticals incInternational journal of virtual realityExchange commissionHead of corporate affairsTrier social stress testSubjective unitsDistress scaleGender differencesStress responsesVirtual reality trier social stressInternational journalVirtual reality